EU publishes final GDP guidelines
March 19, 2013Manufacturing and Production EC, EU, GDP
The European Commission has published the final version of its long-awaited guidelines on Good Distribution Practice (GDP), replacing an earlier …
Hunt: ‘Listen to patients’
March 18, 2013Sales and Marketing Hunt, NHS
A review of NHS complaints handling, aimed at ensuring that all hospitals listen to and act upon the concerns of …
Doctors body joins AllTrials
March 18, 2013Medical Communications, Sales and Marketing alltrials, faculty
The Faculty of Pharmaceutical Medicine has signed up to AllTrials in the latest boost for the campaign for greater trial …
Britannia Pharma appoints marketing director
March 18, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing britannia
Britannia Pharmaceuticals (part of the STADA Arzneimittel group of companies) has appointed Robert Wood as marketing director, for international markets. …
GSK’s Witty: ‘Drugs should be cheaper’
March 15, 2013Manufacturing and Production, Research and Development, Sales and Marketing ABPI, GSK, Witty
Drugs should be cheaper, GlaxoSmithKline boss Sir Andrew Witty said at a conference this week. His comments, reported by Reuters, …
BASF makes organisational changes
March 15, 2013Manufacturing and Production, Research and Development, Sales and Marketing BASF
Leading chemical firm BASF has made a series of appointments in order to reorganise its business operations. Strengthening the Asia-Pacific …
Pulse mistake costs Astellas
March 15, 2013Medical Communications, Sales and Marketing ABPI, Astellas, PMCPA, pulse
A mistake by medical journal Pulse has landed Astellas Pharma in hot water with the PMCPA, enforcers of the ABPI …
Merck makes Alzheimer’s deal
March 14, 2013Research and Development, Sales and Marketing Alzheimer's, Merck
Merck is teaming up with Texas-based Luminex Corporation to develop a companion diagnostic to help in its dementia programme. The …
J&J opens London hub
March 14, 2013Medical Communications, Research and Development, Sales and Marketing J&J, JJ, London, research
Johnson & Johnson has opened the doors to a new life sciences centre in London that forms part of a …
MHRA wins data scam case
March 13, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Aptuit, MHRA, data
An ex-employee of research organisation Aptuit has been found guilty of changing pre-clinical trial data as part of a bid to …
AbbVie guards Humira data
March 13, 2013Sales and Marketing AbbVie, Abbott, Humira, RA, transparency
AbbVie has issued two injunctions against the European Medicines Agency to prevent the regulator revealing data about rheumatoid arthritis drug …
Roche chairman standing down
March 13, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Roche, humer
The chairman of the Board of directors at Roche, Franz Humer, has announced that he will not stand for re-election …
A clinically-led NHS: a new opportunity to improve health
March 13, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CCG, NHS, Portmsouth, hogan, pharmafile
Dr Jim Hogan was speaking at the Prescriber and Pharmafocus conference: CCGs, the new NHS and Pharma in December.First of …
Janssen submits diabetes combination
March 12, 2013Sales and Marketing Janssen, diabetes
Janssen has submitted a combination of its investigational diabetes drug canagliflozin with immediate-release metformin to the European Medicines Agency.The manufacturer, …
Roche bins Galapagos tie-up
March 12, 2013Sales and Marketing COPD, Galapagos, Roche
Roche has ended its three-year old alliance with Belgian drug discovery specialist Galapagos because of a ‘strategic change’. The companies …
NHS Commissioning Board sets out interim arrangements
March 12, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Hakin, NHS
The NHS Commissioning Board has announced interim arrangements for the post of chief operating officer and deputy chief executive. Later …
Impax hit by FDA re-inspection failure
March 11, 2013Manufacturing and Production Impax, hayward
Impax Laboratories has been hit by the news that another (FDA inspection of its troubled manufacturing facility in Hayward, California, …
New AF possibility for Xarelto
March 11, 2013Sales and Marketing Bayer, FDA, Xarelto
Bayer HealthCare is to launch a new trial of its oral blood thinner Xarelto just days after the FDA knocked …
Hospitals not ‘coasting’, Hunt told
March 11, 2013Sales and Marketing Hunt, NHS
Health secretary Jeremy Hunt has angered NHS groups with a speech in which he said some hospitals were ‘coasting’ and …
Merck to close Irish manufacturing unit
March 11, 2013Manufacturing and Production MSD, Merck
Merck & Co has said that a manufacturing unit in Rathdrum, Ireland will close by the end of 2015 with …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
